Novo Nordisk A S (NONOF) stock
NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$38.24−0.60 (-1.53%)
Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –
Novo Nordisk A S price to free cash flow
Price to free cash flow is market cap divided by free cash flow over the trailing twelve months.
Novo Nordisk A S's price to free cash flow was 20.3× on Nov 3, 2026, against 19.1× a year earlier. Over the last 5 years it ranged from 14.3× to 54.9×, with a median of 36.8×.
Price to Free Cash Flow at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 3, 2026 | 20.3× | +0.8 |
| 2025 | Dec 31, 2025 | 19.5× | −13.8 |
| 2024 | Dec 31, 2024 | 33.2× | −13.8 |
| 2023 | Dec 29, 2023 | 47.0× | +2.3 |
| 2022 | Dec 30, 2022 | 44.7× | +7.2 |
| 2021 | Dec 31, 2021 | 37.5× | +10.5 |
| 2020 | Dec 31, 2020 | 26.9× | +0.2 |
| 2019 | Dec 31, 2019 | 26.7× | +4.5 |
| 2018 | Dec 31, 2018 | 22.2× | +1.8 |
| 2017 | Dec 29, 2017 | 20.4× | +0.7 |
| 2016 | Dec 30, 2016 | 19.7× | – |
See a number that looks wrong?